Clinical Trial Update: An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating CSF-1 for temporary correction of presbyopia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• CSF-1

Snippet

Sponsor: Orasis Pharmaceuticals Ltd. | Conditions: Presbyopia | Phase 3 | Status: COMPLETED | Results posted: 2023-11-28